Medicine and Dentistry
Acute Lung Injury
7%
Acute Respiratory Distress Syndrome
33%
Amaurosis
33%
Bronchiectasis
9%
C Reactive Protein
6%
Cathepsin S
38%
Cell Count
15%
Cell Damage
20%
Chronic Lung Disease
38%
Chronic Obstructive Pulmonary Disease
38%
Combination Therapy
38%
Cystic Fibrosis
57%
Cystic Fibrosis Transmembrane Conductance Regulator
38%
Disease Exacerbation
9%
Diseases
16%
Epithelial Cell
6%
Epstein Barr Virus
33%
Epstein-Barr Virus
33%
Host Resistance
9%
Hyperoxia
33%
Immune Response
33%
Immunocompetent Cell
9%
Inflammation
7%
Interleukin 6
6%
Lipopolysaccharide
6%
Lung
33%
Lung Injury
14%
Lung Lavage
26%
Mucosal Immunity
33%
Mucus
38%
Neutrophil
7%
Obstructive Lung Disease
9%
Organ Injury
33%
Pathogenesis
14%
Patient
31%
Placebo
33%
Placebo
33%
Placebo-Controlled Study
6%
Pneumonia
33%
Protein
7%
Proteinase
66%
Proteinase Inhibitor
11%
Real-Time Polymerase Chain Reaction
8%
Respiratory Tract Inflammation
45%
Serositis
33%
Silo-Filler's Disease
42%
Sputum
33%
Therapeutic Procedure
14%
Valaciclovir
33%
Volunteer
6%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lung Injury
7%
Adult Respiratory Distress Syndrome
33%
Bronchiectasis
8%
Cathepsin S
37%
Chronic Lung Disease
37%
Chronic Obstructive Lung Disease
14%
Clinical Trial
9%
Cystic Fibrosis
57%
Cystic Fibrosis Transmembrane Conductance Regulator
37%
Cytokine
6%
Disease Exacerbation
9%
Diseases
16%
Enzyme-Linked Immunosorbent Assay
12%
Fibrosis
33%
Host
42%
Human Epididymis Protein 4
33%
Hypoxia
6%
Inflammation
11%
Interleukin 6
6%
Lung Disease
42%
Lung Injury
13%
Pathogenesis
13%
Pneumonia
33%
Pneumonia
33%
Protein
6%
Proteinase
66%
Proteinase
33%
Proteinase Inhibitor
11%
Respiratory Tract Inflammation
44%
Serine Proteinase
14%
Tumor Necrosis Factor
6%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
9%
Cystic Fibrosis
42%
Imaging Software
16%
Lysozyme
8%
Mucosal Immunity
33%
Protease
100%
Serine Protease
14%
Surface Property
8%
